Michael M. Barch

For more than 30 years, Mr. Barch has held senior management positions in various medical corporations representing nearly every facet of healthcare.  Most recently, Mr. Barch served as Chairman of Global Pharmaceutical Sourcing, a pharmaceutical distribution company.  Previously, he held the post of CEO of The George Washington University Medical Center (GWUMC) for more than 20 years.  During his tenure at GWUMC, he helped the Medical Center develop a 300-physician group practice and a 100,000-member HMO.  He later served as Assistant VP at Johns Hopkins University School of Medicine.  Following his appointment at Johns Hopkins, Mr. Barch was named President and CEO of Managed Care Assistance Corporation (MCAC) which was responsible for the development of six different statewide managed care networks and the formation of HMOs in two additional states.  Mr. Barch holds a joint degree in economics and finance from the University of Louisiana at Lafayette and a MHSA from The George Washington University.

Alan R. Goldhammer, PhD

Dr. Goldhammer is an expert in drug regulatory affairs and policy.  He recently served as Vice President, Scientific and Regulatory Affairs at the Pharmaceutical Research and Manufactures of America (PhRMA) where he was responsible for maintaining a liaison with the Food and Drug Administration (FDA).  While at PhRMA, Dr. Goldhammer served as the lead spokesperson on drug safety, clinical trial transparency, pharmaceutical development and other technical/regulatory issues.  He also directed a task force that brought to conclusion the Observational Medical Outcomes Partnership which gained PhRMA Board approval in 2008.  Previously, he held the position of Executive Director for Technical Affairs at Biotechnology Industry Organization (BIO) where he coordinated regulatory and scientific policy across, served as the lead BIO negotiator responsible for joint industry-FDA agreements on the Prescription Drug User Fee Act and as co-principal lobbyist for BIO responsible for securing passage of the Food and Drug Modernization Act of 1997.  Prior positions include Senior Staff Fellow at the NIH and lecturer in Biochemistry at Indiana University.  Dr. Goldhammer holds a BA in Chemistry from the University of California at Santa Barbara, and a PhD in Biological Chemistry from Indiana University.

Bruce Roberts

Mr. Roberts served as Executive Vice President and CEO of the National Community Pharmacists Association (NCPA) from 2001 until 2010.  Prior to joining NCPA he owned and operated pharmacies in Northern Virginia for 25 years. During his tenure at NCPA he played a pivotal role in the formation of SureScripts a company focused on facilitating the connection between prescribers and pharmacies for the provision of electronic prescribing.  He has devoted his professional life to the advancement of independent, community pharmacy and pharmacist-centered patient care.  He is a staunch supporter of the vital role that pharmacists can and must play in our increasingly complex health care delivery system.   Mr. Roberts also led the formation of Mirixa a company focused on connecting the pharmacist with those that want to engage them in the delivery of clinical services.  Mirixa has grown to be the industry leader in the Medication Therapy Management space as well as other areas of clinical services provided by pharmacist.  Mr. Roberts served as the Chairman of both the Mirixa and Surescripts Board of directors until his retirement from NCPA in 2010.

Ronald J. Streck

Mr. Streck is President and CEO and founder of Rx Distribution Network™, LLC (RxDN).   With over 35 years of experience, he has extensive background in the pharmaceutical and pharmaceutical distribution industry. In 2004, Streck established a network (RxDN) of 13 Regional Distributors committed to a safe and secure distribution of pharmaceutical products.  Previously, Mr. Streck co-established an auditing division at Health Pathways Inc., SynTegra, which provides pharmaceutical and biotechnology clients a configurable suite of compliance management, inventory management and technology and process auditing services to better manage and fully satisfy their operational and regulatory compliance needs. For 27 years, Mr. Streck held various positions in HDMA (Healthcare Distribution Management Association), a national trade association representing all major U.S. distributors and manufacturers of pharmaceutical products. He began as Staff Attorney and State Government Affairs Manager.  He later moved to Vice President of Government Affairs.  In 1992, he became President and CEO of HDMA and retired in 2003.  Mr. Streck has a BS in Pharmacy, an MBA and a JD degree.